摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-溴苯基)-3-苯基-丙酸 | 80272-20-4

中文名称
3-(4-溴苯基)-3-苯基-丙酸
中文别名
——
英文名称
3-(4-bromophenyl)-3-phenyl-propionic acid
英文别名
3-(4-bromophenyl)-3-phenylpropanoic acid;3-(4-Brom-phenyl)-3-phenyl-propionsaeure
3-(4-溴苯基)-3-苯基-丙酸化学式
CAS
80272-20-4
化学式
C15H13BrO2
mdl
——
分子量
305.171
InChiKey
YWVPNKXYIIUHMY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-(4-溴苯基)-3-苯基-丙酸三氯化铝 作用下, 反应 18.0h, 以45%的产率得到3-(4-bromophenyl)-2,3-dihydro-1H-inden-1-one
    参考文献:
    名称:
    3-苯基-1-茚满胺。潜在的抗抑郁活性和对多巴胺,去甲肾上腺素和5-羟色胺摄取的有效抑制。
    摘要:
    合成了一系列3-苯基-1-茚满胺,并测试了其潜在的抗抑郁活性以及对多巴胺(DA),去甲肾上腺素(NE)和5-羟色胺(5-HT)吸收的抑制作用。反式异构体通常是DA,NE和5-HT吸收的有效抑制剂,而顺式异构体则优先抑制5-HT的吸收。对DA吸收位点的亲和力非常取决于芳族取代模式,其中3',4'-二氯取代的化合物的效价最高(45)。这种取代模式也导致了对NE和5-HT摄取位点的高度亲和力,但是用其他取代模式也可以获得强大的5-HT摄取抑制活性。在5-HT摄取部位只能容纳少量胺,而在DA和NE摄取部位都可以容纳较大的胺(例如哌嗪)。观察到的构效关系是根据反式(45)和顺式(72)异构体分别与5-HT和DA重叠的结果解释的,与拟议的摄取抑制剂在摄取时的三点结合有关网站。最后,比较了3-苯基-1-茚满胺与其他新型双环儿茶酚胺和/或5-羟色胺摄取抑制剂的结构,发现它们对有效抑制DA-,NE-和/或5-HT摄取具有重要意义。
    DOI:
    10.1021/jm00150a012
  • 作为产物:
    描述:
    1-(alpha-氯苄基)-4-溴苯氢氧化钾 、 sodium hydride 、 sodium iodide 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 50.17h, 生成 3-(4-溴苯基)-3-苯基-丙酸
    参考文献:
    名称:
    Ring-substituted histaprodifen analogues as partial agonists for histamine H1 receptors: synthesis and structure–activity relationships
    摘要:
    Thirteen racemic benzene ring-substituted analogues of histaprodifen (8a; 2-[2-(3,3-diphenylpropyl)-1H-imidazol-4-yl]ethanamine), a novel lead for potent and selective histamine H-1-receptor agonists, have been prepared from substituted 4,4-diphenylbutyronitriles 5 via cyclization of the corresponding methyl butyrimidates 6 with 2-oxo-4-phthalimido-1-butyl acetate in liquid ammonia, followed by deprotection. Nitriles 5 were accessible by alkylation of either substituted diphenylmethanes with 3-bromopropionitrile or diethyl malonate with substituted 1-chloro-diphenylmethanes and subsequent standard reactions. The title compounds 8 displayed partial agonism on contractile H-1 receptors of the guinea-pig ileum (E-max = 2-98% relative to histamine) and, compared with the endogenous agonist, were endowed with agonist potencies of 4-92%. The meta fluorinated (gc) and meta chlorinated (8f) analogues showed the highest relative potency in this series (95% confidence Limits 85-99% and 78-102%), but did not exceed the value of the lead 8a (99-124%). Compound 8c (2-[2-[3-(3-fluorophenyl)-3-phenylpropyl]-1H-imidazol-4-yl]ethanamine) was a partial agonist at contractile H-1 receptors of the guinea-pig aorta (relative potency 154% vs. 100% for histamine) and at relaxation-mediating endothelial H-1 receptors of the rat aorta (relative potency 556% vs. 100% for histamine) and matched with the functional behaviour of 8a. Agonism observed for each compound was sensitive to blockade by the selective H-1-receptor antagonist mepyramine (pA(2) approximate to 9 (guinea-pig) and pA(2) approximate to 8 (rat aorta)). All histaprodifen analogues 8 stimulated neither histaminergic H-2/H-3, nor cholinergic M-3 receptors. They displayed only low to moderate affinity for these sites (H-2: pD'(2), < 5; H-3/M-3: pA(2) < 6). With regard to the substitution pattern on the benzene ring, there was no correlation between the histaprodifen series and the corresponding derivatives of another selective H-1-receptor agonist, viz. 2-phenylhistamine. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
    DOI:
    10.1016/s0223-5234(00)00105-7
点击查看最新优质反应信息

文献信息

  • Development of Modifiable Bidentate Amino Oxazoline Directing Group for Pd-Catalyzed Arylation of Secondary CH Bonds
    作者:Kang Chen、Zhao-Wei Li、Peng-Xiang Shen、Hong-Wei Zhao、Zhang-Jie Shi
    DOI:10.1002/chem.201406528
    日期:2015.5.11
    A novel bidentate α‐amino oxazolinyl directing group has been developed. Different from previous directing groups, this newly designed directing group was easily prepared from amino acids and modified in structure. This auxiliary preferentially effects functionalization at secondary C(sp3)H bonds, rather than at aryl C(sp2)H bonds. The diastereoselectivity of direct arylation between geminal secondary
    一个新的双齿α-氨基恶唑啉基导向基团已经开发出来。与以前的指导小组不同,这个新设计的指导小组很容易从氨基酸制备并进行结构修饰。该辅助剂优先在二级C(sp 3)H键上而不是在芳基C(sp 2)H键上进行功能化。线性分子中的双键仲C(sp 3)H键之间直接芳基化的非对映选择性也首次通过远程手性中继与手性导向基团实现。通过改变底物和芳基卤化物的取代基,可以用相同的手性来源制得两种非对映异构体。
  • Electrochemical oxidative decarboxylation and 1,2-aryl migration towards the synthesis of 1,2-diaryl ethers
    作者:Faxiang Bu、Lijun Lu、Xia Hu、Shengchun Wang、Heng Zhang、Aiwen Lei
    DOI:10.1039/d0sc03708g
    日期:——
    also radical precursors. Classic transition-metal-catalyzed and photochemical decarboxylation have shown their excellent site selectivity in radical chemistry. However, electrochemical decarboxylation with a long history hasn't got enough attention in recent years. In this work, the electrochemical oxidative decarboxylation and 1,2-aryl migration of 3,3-diarylpropionic acids have been introduced to construct
    羧酸化合物是重要的化学物质,广泛存在于各种天然产物中。它们不仅是亲核试剂,还是自由基的前体。经典的过渡金属催化和光化学脱羧在自由基化学中显示出出色的位点选择性。但是,近年来,电化学脱羧历史悠久,尚未引起足够的重视。在这项工作中,已引入3,3-二芳基丙酸的电化学氧化脱羧和1,2-芳基迁移,以与醇构建C–O键。值得注意的是,这种转变无需金属催化剂和外部氧化剂即可顺利进行。
  • [EN] NEW DIFLUOROKETAMIDE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE DIFLUOROCÉTAMIDE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2016180751A1
    公开(公告)日:2016-11-17
    The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as described herein, compositions including the compounds and methods of using the compounds.
    该发明提供了具有一般化学式(I)的新化合物,其中R1、R2、R3、R4、R5、R6、R7、R8和R9如本文所述,包括这些化合物的组合物以及使用这些化合物的方法。
  • Difluoroketamide derivatives
    申请人:Hoffmann-La Roche Inc.
    公开号:US10428108B2
    公开(公告)日:2019-10-01
    The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as described herein, compositions including the compounds and methods of using the compounds.
    本发明提供了具有通式 (I) 的新型化合物 其中 R1、R2、R3、R4、R5、R6、R7、R8 和 R9 如本文所述,还提供了包括这些化合物的组合物和使用这些化合物的方法。
  • An Apparently Anomalous Bromination in the Polyphenylindene Series
    作者:C. F. H. Allen、J. W. Gates
    DOI:10.1021/ja01243a031
    日期:1943.3
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐